Found vs Calibrate: Genetic Context for GLP-1 Provider Selection

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Choosing between telehealth providers requires more than cost comparison. Understanding your genetic predispositions in peptide signaling pathways—such as GIPR variants—can provide clinical context for which program model and medication formulation may align with your overall health strategy. PlexusDx emphasizes precision-wellness decision-making through biomarker and genetic insights, supporting a more informed conversation with whichever provider you ultimately select.

Program Structure and Clinical Model Differences

Found emphasizes monthly visits with a registered nurse or physician assistant, focusing on rapid optimization and side-effect management. Calibrate combines medication access with behavioral coaching and longer-term monitoring, positioning itself as a comprehensive weight-loss program. Both models have merit; your choice depends on whether you prefer frequent clinical touchpoints or a structured behavioral framework alongside medication.

Full head-to-head: PlexusDx vs Found →

Neither program is inherently superior—program fit depends on your baseline health literacy, comfort with self-monitoring, and preference for ongoing behavioral support versus medication-focused optimization. If you have metabolic complexity or prior medication sensitivities, more frequent clinical contact may benefit you. If structured coaching resonates with your learning style, Calibrate's integrated model may be appealing.

Cost, Access, and Insurance Coverage Landscape

Found runs two separate tracks, and it is important to keep them apart. Found's cash compounded-semaglutide program is $289/month (multi-month prepaid plans run $249/mo for 3 months, $219/mo for 6 months, or $169/mo for 12 months), billed every four weeks — 13 charges a year on the monthly plan — with medication included and no separate membership fee. Compounded tirzepatide is $359/month cash. Separately, covered patients on Found's insurance track may pay from $99/month; that insurance figure applies only to covered patients and should never be read as a cash price. Calibrate's model is generally higher at $250–$300+ monthly, reflecting the integrated coaching and longer appointment duration (per Calibrate's published rates as of July 2026; verify on their site).

Factor	Found	Calibrate
Typical Monthly Cost	Cash: $289/mo compounded semaglutide or $359/mo compounded tirzepatide, medication included; separate insurance track from $99/mo for covered patients (verified July 2026)	$250–$300+ (per Calibrate's published rates; verify on their site)
Insurance Acceptance	Variable by plan	Variable by plan
Clinical Visit Frequency	Monthly (default)	Monthly + coaching calls
Medication Type	Compounded semaglutide or compounded tirzepatide from partner pharmacies (compounded program; no generic semaglutide exists)	Brand-name GLP-1s (Ozempic, Wegovy, Mounjaro), typically via insurance
Onboarding Assessment	Telehealth intake	Expanded metabolic history

Genetic Predispositions and Medication Response Variability

GLP-1 response varies widely between individuals, driven by genetics, gut microbiota, insulin sensitivity, and metabolic baseline. Key genetic variants in GIPR and FTO, and MC4R pathways may correlate with how your body processes and responds to peptide medications. Neither Found nor Calibrate routinely test for these predispositions, meaning both rely on empirical dose escalation and side-effect reporting during treatment.

Understanding your peptide pathway genetics does not predict exact medication response, but it may provide clinical context for why you experience certain side effects or weight-loss trajectories. For example, FTO rs9939609 variants correlate with baseline adiposity and appetite regulation; GIPR rs1800437 relates to glucose-dependent insulinotropic peptide signaling. This information can support a more nuanced conversation with any provider about medication formulation, dosing pace, and realistic expectations.

Safety Considerations and Who Benefits Most from Each Model

Found's frequent monthly visits support rapid identification of adverse effects like nausea, constipation, or pancreatitis symptoms, making it suitable for patients with complex comorbidities or polypharmacy. Calibrate's behavioral coaching can benefit patients who struggle with satiety signaling dysfunction or emotional eating; the structured program may improve long-term adherence and lifestyle integration. Neither model addresses genetic risk factors directly unless you proactively seek testing elsewhere.

Common GLP-1 side effects—nausea, vomiting, constipation, and risk of dehydration—require clinical monitoring regardless of program choice. Patients with personal or family history of thyroid cancer, pancreatitis, or multiple endocrine neoplasia type 2 should disclose these to any provider. Both platforms screen for contraindications, but your genetic profile may inform which medication formulation or titration schedule a provider recommends for safer dosing.

How PlexusDx Supports a More Personalized Approach

PlexusDx offers compounded GLP-1 medications—semaglutide and tirzepatide from licensed 503A pharmacies—at $189/mo month-to-month for semaglutide injection (tirzepatide injection $289/mo). That sits below Found's $289/mo standard cash rate, though Found also sells a 12-month prepaid plan that PlexusDx does not offer, and Found runs a separate insurance track for covered patients. Compounded options may provide cost-effective access while allowing you to work with a telehealth provider of your choice (Found, Calibrate, or your primary care physician). Pricing alone does not determine clinical fit; understanding your genetic context in peptide pathways may help you prioritize which program features matter most to your health goals.

PlexusDx Precision Peptide Genetic Test ($298) reveals predispositions in GIPR, FTO, and MC4R pathways. These variants do not predict exact medication response or guarantee weight loss; instead, they may provide clinical context about your baseline appetite regulation, insulin sensitivity, and metabolic risk profile. This information is most useful when interpreted alongside your healthcare provider's clinical assessment, not as a standalone decision tool.

If you are comparing Found and Calibrate, consider requesting that your chosen provider review your Precision Peptide Genetic Test results as part of your baseline assessment. This may support a more informed conversation about medication formulation choice, expected titration pace, and realistic side-effect management. PlexusDx compounded medications can work within either telehealth ecosystem, giving you flexibility to select the program model that fits your preferences while leveraging genetic insights for personalization.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

What is the main difference between Found and Calibrate?

Found emphasizes frequent clinical visits and rapid medication optimization, while Calibrate integrates behavioral coaching and longer-term program structure. On cost, Found's cash compounded-semaglutide program is $289/month (separate insurance track from $99/month for covered patients), while Calibrate generally runs $250–$300+ monthly; Calibrate offers more comprehensive coaching. Both offer telehealth GLP-1 access with variable insurance coverage.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to GLP-1 medications or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How does PlexusDx fit into the Found vs Calibrate decision?

PlexusDx offers compounded semaglutide and tirzepatide through licensed 503A pharmacies at $189/mo month-to-month — below Found's $289/mo standard cash rate; Found also sells a 12-month prepaid plan, a term PlexusDx does not offer, plus an insurance track for covered patients. You can use PlexusDx medications while working with either program or your primary provider, giving you flexibility in program choice and cost management.

What safety monitoring should I expect with GLP-1 treatment?

Both Found and Calibrate screen for contraindications and monitor for nausea, vomiting, constipation, dehydration, and rare pancreatitis. Frequent clinical visits (Found) or behavioral check-ins (Calibrate) support early adverse-effect detection.

Does PlexusDx Precision Peptide Genetic Test help me choose between Found or Calibrate?

The test reveals predispositions in peptide pathways that may inform your baseline metabolic profile, but does not predict which program is best for you. Results should be shared with your chosen provider to support personalized treatment planning and realistic expectation-setting around side effects and weight-loss pace.

Related Reading

• Remedy Meds Cost
• Lifemd Cost
• Found Glp 1
• Hers Cost

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.